Characterization of the triage process in neonatal intensive care

Pediatrics

Volumn 102, Issue 6, 1998, Pages 1432-1436

  Zupancic, John A F ^a   Richardson, Douglas K ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cost analysis; Economics; Infant, newborn; Neonatal intensive care; Resource utilization

Indexed keywords

ARTICLE; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RESOURCE MANAGEMENT; SCORING SYSTEM;

EID: 0031771781     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.102.6.1432     Document Type: Article

References (25)

1. Rogowski J. Cost-effectiveness of care for very low birth weight infants. Pediatrics. 1998;102:35-43
2. Stevenson RC, Pharoah PO, Stevenson CJ, et al. Cost of care for a geographically determined population of low birthweight infants to age 8-9 years II Children with disability. Arch Dis Child Fetal and Neonatal Ed. 1996;74:F118-F121
3. Boyle MH, Torrance GW, Sinclair JC, et al. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med. 1983;308:1330-1337
4. US Congress, Office of Technology Assessment. Neonatal Intensive Care for Low Birth Weight Infants: Costs and Effectiveness (Health Technology Case Study 38), OTA-HCS-38. Washington, DC: US Congress, Office of Technology Assessment; 1987
5. Tubman TR, Halliday HL, Normand C. Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial. Br Med J. 1990;301:842-845
6. Phibbs CS, Phibbs RH, Wakeley A, et al. Cost effects of surfactant therapy for neonatal respiratory distress syndrome. J Pediatr. 1993;123: 953-962
7. Mauskopf JA, Backhouse ME, Jones D, et al. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: impact on hospital resource use and charges, J Pediatr. 1995;126:94-101
8. DiWaker K, Roberts S, John E. Surfactant replacement therapy in neonates less than 32 weeks gestation: effect on neonatal intensive care resource utilization. J Paediatr Child Health. 1993;29:434-437
9. Mansicalco WM, Kendig JW, Shapiro DL. Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome. Pediatrics. 1989;83:1-6
10. Shireman TI, Hilsenrath PE, Strauss RG, et al. Recombinant erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis. Arch Pediatr Adolesc Med. 1994;148:582-588
11. Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomised, placebo-controlled trial. J Pediatr. 1995;126:421-426
12. American Academy of Pediatrics. Guidelines for Perinatal Care. 4th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997
13. Weingarten S, Ermann B, Bolus R, et al. Early "step-down" transfer of low-risk patients with chest pain. A controlled interventional trial. Ann Intern Med. 1990;113:282-289
14. Derlet RW, Kinser D, Ray L, et al. Prospective identification and triage of nonemergency patients out of an emergency department: a 5-year study. Ann Emerg Med. 1995;25:215-223
15. Ochsner MG, Schmidt JA, Rozycki GS, et al. The evaluation of a two-tier trauma response system at a major trauma center: is it cost effective and safe? J Trauma. 1995;39:971-977
16. Richardson DK, Gray JE, McCormick MC, et al. Score for neonatal acute physiology (SNAP): validation of a new physiology-based severity of illness index. Pediatrics. 1993;91:617-623
17. Gray JE, Richardson DK, McCormick MC et al. Neonatal therapeutic intervention scoring system: A therapy-based severity of illness index. Pediatrics. 1992;90:561-567
18. Campbell DM. Why do physicians in neonatal care units differ in their admission thresholds? Soc Sci Med. 1984;18:365-374
19. Cloherty JP, Stark AR. Manual of Neonatal Care. Boston, MA: Little, Brown & Co; 1980
20. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR. 1996;45(No. RR-7):1-24
21. Halsey NA, Schuchat A, Oh W, Baker CJ. The 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. Pediatrics. 1997; 100:383-384
22. Lieberman E, Lang JM, Frigoletto F Jr, et al. Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics. 1997;99: 415-419
23. Rich EC, Gifford G, Luxenberg N, et al. The relationship of house staff experience to the cost and quality of inpatient care. JAMA. 1990;263: 953-957
24. Long SH, Marquis MS, Harrison ER. The costs and financing of perinatal care in the United States. Am J Public Health. 1994;84:1473-1478
25. Finkler SA. The distinction between costs and charges. Ann Intern Med. 1982;96:102-109